Browse by author
Lookup NU author(s): Professor Tim Goodship,
Dr Liz Kemp
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Membrane cofactor protein (MCP, CD46) is a widely expressed transmembrane complement regulator. As does the soluble regulator factor H, it inhibits complement activation by inactivating the C3b that is deposited on target membranes. Factor H mutations have been described in 15-30% of patients with atypical haemolytic uraemic syndrome (HUS). Recent studies have identified mutations in the MCP gene in four families. In one, a heterozygous deletion resulted in the intracellular retention of the mutant protein. In another, a different heterozygous deletion led to a premature stop codon and the loss of the C-terminus. In the other two, a substitution (S206P) resulted in cell-surface expression but inefficient inactivation of surface-bound C3b. These findings provide further evidence that complement dysregulation predisposes to the development of HUS.
Author(s): Goodship THJ, Liszewski MK, Kemp EJ, Richards A, Atkinson JP
Publication type: Article
Publication status: Published
Journal: Trends in Molecular Medicine
Print publication date: 01/05/2004
ISSN (print): 1471-4914
ISSN (electronic): 1471-499X
PubMed id: 15121049
Altmetrics provided by Altmetric